Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recognition of an allograft.

P J Morris

    Nephrologie
    |January 1, 1986
    PubMed
    Summary

    Understanding tissue allograft rejection is complex. Key factors include major histocompatibility complex (MHC) and minor histocompatibility antigens, with passenger leukocytes playing a crucial role in the immune response.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The immunobiology of cell transplantation.

    Transplantation proceedings·1992
    Same author

    The role of T suppressor cells in the maintenance of spontaneously accepted orthotopic rat liver allografts.

    Transplantation·1992
    Same author

    Immunological advances in clinical transplantation.

    Transplantation proceedings·1992
    Same author

    Phenotypic and functional analysis of graft-infiltrating cells following therapy with anti-interleukin-2 receptor monoclonal antibody and cyclosporine A in the rat.

    Transplantation proceedings·1992
    Same author

    Diabetes and frontiers of research. Introduction.

    Diabetologia·1992
    Same author

    Reductive debromination of the commercial polybrominated biphenyl mixture firemaster BP6 by anaerobic microorganisms from sediments.

    Applied and environmental microbiology·1992

    Area of Science:

    • Immunology
    • Transplantation immunology

    Background:

    • Allograft recognition as foreign and subsequent immune response are complex and multifactorial.
    • Major histocompatibility complex (MHC) incompatibility is critical, with both Class I (e.g., HLA-A, B) and Class II (e.g., HLA-DR) antigens inducing responses.
    • Under certain conditions, MHC Class I antigen presentation on viable cells can lead to suppression instead of rejection.

    Purpose of the Study:

    • To elucidate the complex mechanisms underlying tissue allograft rejection.
    • To investigate the roles of MHC and minor histocompatibility antigens in allograft immunity.
    • To explore the significance of antigen presentation pathways, including the role of passenger leukocytes.

    Main Methods:

    • Review of existing literature on allograft rejection mechanisms.
    • Analysis of the roles of MHC Class I and Class II antigens in immune induction.
    • Examination of antigen presentation pathways involving host antigen-presenting cells and donor passenger leukocytes (dendritic cells).

    Main Results:

    • MHC incompatibility is a primary driver of allograft rejection.
    • Two main antigen presentation pathways exist: host APCs presenting alloantigen with host Ia, or donor passenger leukocytes presenting alloantigen directly to host T helper (TH) cells.
    • Passenger leukocytes, particularly dendritic cells, appear to play a significant role in initiating the allograft response.
    • Minor histocompatibility antigens can also elicit immune responses, especially when MHC is compatible.

    Conclusions:

    • Allograft rejection involves intricate interactions between donor antigens and host immune systems.
    • The presentation of histocompatibility antigens by both host and donor cells, particularly passenger leukocytes, is crucial for initiating immune responses.
    • Further research into minor histocompatibility antigens is warranted, given their potential to induce rejection even with MHC compatibility.

    Related Experiment Videos